Opportunities for sustainable animal agriculture: addressing antibiotics risk and protecting human health
This event is invite only. If you are an institutional investor interested in attending this event, please contact Rosie Wardle for further details.
The Interfaith Corporate Responsibility Center (ICCR) and the FAIRR Initiative are convening this multi-stakeholder roundtable “Opportunities for Sustainable Animal Agriculture: Addressing Antibiotic Risk and Protecting Human Health” as an open dialogue between investors and stakeholders from both the supply and demand sides of the meat distribution chain – producers, meat processors, suppliers, restaurants, retailers, industry trade associations, and consumer groups.
Cognizant of the investment risks linked to this issue – particularly reputational damage and loss of market share associated with changing consumer preference and future regulation, in addition to the public health risks – stakeholders will share perspectives on how to identify and address these risks and explore strategies and opportunities that promote safe and scalable meat production without the routine use of antibiotics. Seeking to replicate recent progress made in sustainable sourcing of chicken, the Roundtable will focus on the special challenges presented by beef and pork.
According to the Centers for Disease Control (CDC), at least two million Americans fall sick and at least 23,000 die each year due to antibiotic resistance infections (by very conservative estimates). There is widespread concern about the use of antibiotics in animal husbandry. If no action is taken, antibiotic resistance could cause 300 million premature deaths and up to $100 trillion in global economic damage by 2050 — and virtually eliminate many surgeries.
Both investor and consumer expectation is growing that restaurants and their suppliers will begin to take a more holistic approach to addressing the challenges of antibiotics resistance in all parts of their meat supply chains, by setting sourcing targets and timelines, especially for beef and pork, across all markets in which they operate. We recognise, however, that making such commitments is not without challenges. In this roundtable we will explore what those challenges are, and seek to collaboratively arrive at some viable solutions to address them.
For 15 years, ICCR members have been engaging corporations on the public health risks posed by this issue. ICCR members advocate for “no routine use” — no use of antibiotics for growth promotion and no regular or repeated use for disease prevention, particularly for antibiotics that are important in human medicine. We support use that is limited to treatment of animals diagnosed with an illness or controlling a disease outbreak.
In 2016, FAIRR brought together a coalition of over 70 investors with combined assets of more than $2.4trillion to engage with 10 global restaurant chains on antibiotics policies. This engagement has recently been expanded to 10 additional companies.